Medical devices, healthcare technology and the business of care
PMA SUPPLEMENT · P010015/S591

Percepta Bipolar CRT-P (W1TR01); Percepta Quadripolar CRT-P (W4TR01); Serena Bipolar CRT-P (W1TR02); Serena Quadripolar

Medtronic, Inc. · Decision date Oct 23, 2026

MEDTECHLEDGER EXPLANATIONP010015/S591

What did the FDA decide?

This 30-day notice describes a manufacturing process change for Medtronic pacemaker models listed under PMA P010015. The stated change is the introduction of a second Medium Rate (MR) Headers manufacturing line and inspection updates to the MR Headers line currently in production.

The supplement type is a 30-Day Notice, and the supplement reason is a process change involving manufacturer, sterilizer, packager, or supplier. The decision code OK30 indicates the notice was accepted. The source statement reports the intended manufacturing change but does not provide independent proof of safety or clinical effectiveness. Specific details about the inspection updates are absent from the supplied fields.

FDA approval order statement

the introduction of a second Medium Rate (MR) Headers manufacturing line and to make inspection updates to the MR Headers Line that is currently in production
Regulatory pathway
PMA supplement
Supplement type
30-Day Notice
Clinical specialty
Cardiovascular
Decision date
Oct 23, 2026
FDA change category
Process Change - Manufacturer/Sterilizer/Packager/Supplier

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
P010015/S591
Regulatory pathway
PMA supplement
Product code
LWP
Decision code
OK30
Decision date
Oct 23, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Implantable pulse generator, pacemaker (non-CRT).

Product code
LWP
FDA device class
3

For the original device and its historical approval scope, see PMA P010015. Subsequent supplements may change the device or its indications.

FDA decision timeline

  1. P010015 · Original PMA

    MEDTRONIC INSYNC(TM) BIVENTRICAL PACING SYSTEM

  2. P010015/S591 received

    Application receipt date recorded by FDA.

  3. P010015/S590 · Related supplement

    Percepta Bipolar CRT-P, Percepta Quadripolar CRT-P, Serena Bipolar CRT-P, Serena Quadripolar CRT-P, Solara Bipolar CRT-P

  4. P010015/S591 · FDA decision

    30-Day Notice

  5. P010015/S592 · Related supplement

    Percepta Bipolar CRT-P; Percepta Quadripolar CRT-P; Serena Bipolar CRT-P; Serena Quadripolar CRT-P; Solara Bipolar CRT-P

Timeline entries are records held by MedtechLedger for P010015. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P010015

Explore the linked device profile

Other records with product code LWP

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Medtronic, Inc.

Headquarters
Not reported
Brand website
medtronic.com
FDA applicant address
8200 Coral Sea St. N.E, Ms Mvs11, Mounds View, MN, 55112

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records